Photo by sharonmccutcheon from unsplash
Ursodeoxycholic acid (UDCA) is a secondary hydrophilic bile acid (BA) used as therapy for a range of hepatobiliary diseases. Its efficacy in non‐alcoholic fatty liver disease (NAFLD) is still under… Click to show full abstract
Ursodeoxycholic acid (UDCA) is a secondary hydrophilic bile acid (BA) used as therapy for a range of hepatobiliary diseases. Its efficacy in non‐alcoholic fatty liver disease (NAFLD) is still under debate. Here, we aimed to decipher molecular mechanisms of UDCA in regulating endoplasmic reticulum (ER) homeostasis, apoptosis and oxidative stress in morbidly obese patients.
Keywords:
apoptosis oxidative;
morbidly obese;
ursodeoxycholic acid;
stress morbidly;
obese patients;
oxidative stress
Journal Title: Liver International
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Liver International
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!